共 5 条
- [1] RESISTANCE (R) AND CROSS-RESISTANCE (XR) OF HUMAN OVARIAN-CANCER (OC) CELL-LINES TO ADRIAMYCIN (AD), MELPHALAN (ME) AND IRRADIATION (XRT) [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 336 - 336
- [2] INCREASED DNA-REPAIR IN HUMAN OVARIAN-CANCER (OC) CELL-LINES (CL) WITH INDUCED RESISTANCE (R) TO CISPLATIN (P) OR MELPHALAN (M) [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 264 - 264
- [3] DEVELOPMENT OF DRUG SENSITIVE (S) AND RESISTANT (R) HUMAN OVARIAN-CANCER (OC) CELL-LINES (CL) - A MODEL SYSTEM FOR INVESTIGATING NEW DRUGS AND MECHANISMS OF RESISTANCE [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 313 - 313
- [4] AUGMENTATION OF ADRIAMYCIN (AD), MELPHALAN (ME), AND CISPLATIN (CP) CYTO-TOXICITY (CT) BY BUTHIONINE SULFOXIMINE DEPLETION OF GLUTATHIONE (GSH) IN DRUG (D) RESISTANT (R) HUMAN OVARIAN-CANCER (OC) CELL-LINES (CL) [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 345 - 345
- [5] THE EFFECT OF AMPHOTERICIN-B (AMB) ON THE CYTO-TOXICITY OF ADRIAMYCIN (ADR) AND L-PHENYLALANINE MUSTARD (LPAM) IN L1210 LEUKEMIA, IN MURINE OVARIAN-CANCER (OC), AND IN AN INVITRO PHASE-II TRIAL USING THE HUMAN-TUMOR STEM-CELL ASSAY (HTSCA) IN RELAPSED OC PATIENTS (PTS) [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 254 - 254